571 related articles for article (PubMed ID: 17412809)
1. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
2. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
[TBL] [Abstract][Full Text] [Related]
3. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
Potter LR
Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
[TBL] [Abstract][Full Text] [Related]
7. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta.
Drewett JG; Fendly BM; Garbers DL; Lowe DG
J Biol Chem; 1995 Mar; 270(9):4668-74. PubMed ID: 7876238
[TBL] [Abstract][Full Text] [Related]
9. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
Thibault G; Grove KL; Deschepper CF
Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
[TBL] [Abstract][Full Text] [Related]
10. Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.
Dickey DM; Dries DL; Margulies KB; Potter LR
J Mol Cell Cardiol; 2012 Mar; 52(3):727-32. PubMed ID: 22133375
[TBL] [Abstract][Full Text] [Related]
11. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
[TBL] [Abstract][Full Text] [Related]
13. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
Savoie P; de Champlain J; Anand-Srivastava MB
FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
[TBL] [Abstract][Full Text] [Related]
15. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.
Potter LR
Pharmacol Ther; 2011 Apr; 130(1):71-82. PubMed ID: 21185863
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide receptor-C signaling and regulation.
Anand-Srivastava MB
Peptides; 2005 Jun; 26(6):1044-59. PubMed ID: 15911072
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine impairs the guanylyl cyclase activity of the natriuretic peptide receptor in the glomerulus.
Kook H; Kim SW; Kang SY; Kim SZ; Kim JH; Choi KC; Lee J; Cho KW; Baik YH
Pharmacol Res; 2000 Nov; 42(5):435-41. PubMed ID: 11023705
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
Abbey SE; Potter LR
Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
[TBL] [Abstract][Full Text] [Related]
19. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
Christoffersen C; Bartels ED; Nielsen LB
Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
[TBL] [Abstract][Full Text] [Related]
20. [Natriuretic peptide system].
Itoh H; Nakao K
Nihon Rinsho; 1997 Aug; 55(8):1923-36. PubMed ID: 9284403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
